Abstract
The last 20 years has seen rapid advances in genomics, proteomics and other omics technologies, with both the human genome and proteome now being at >90% completion at high stringency.1 This same period has also seen a paradigm shift in medical treatment from the traditional ‘one size fits all’ approach, where all patients receive the same standardised treatment for a particular disease, to a personalised/precision medicine (PM) approach where treatment is tailored for an individual based on an understanding of their individual systems biology (comprehensive in-depth monitoring of genes, proteins) and disease related pathways, lifestyle and environmental factors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
